Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Institut Bergonié
Washington University School of Medicine
Incyte Corporation
Trishula Therapeutics, Inc.
Institut Bergonié
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Taproot Health
The Christie NHS Foundation Trust
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Sanguine Biosciences
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Assistance Publique - Hôpitaux de Paris
Biologics & Biosimilars Collective Intelligence Consortium
Eastern Cooperative Oncology Group
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Institut Bergonié
Mid and South Essex NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Celgene
Dana-Farber Cancer Institute
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
LEO Pharma
Northwell Health
University of Chicago
British Columbia Cancer Agency
National Institutes of Health Clinical Center (CC)
Amgen
Royal Brompton & Harefield NHS Foundation Trust
Ohio State University Comprehensive Cancer Center
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
AHS Cancer Control Alberta
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Sandoz
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Stanford University
Valerio Therapeutics
Philogen S.p.A.
University of Chicago
National Cancer Institute (NCI)
Altor BioScience